Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00793910 · ClinicalTrials.gov registry record · NA
Oral Gabapentin Versus Placebo for Treatment of Postoperative Pain Following Photorefractive Keratectomy
A NA study, sponsored by Walter Reed Army Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT00793910 is a NA study that has completed, run by Walter Reed Army Medical Center. The registered enrollment target is 106 participants.
The verdict
NCT00793910, a NA study, has completed, sponsored by Walter Reed Army Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of an oral medication called gabapentin in reducing pain after Photorefractive Keratectomy (PRK) eye surgery and to assess the frequency of use of rescue medication interventions, defined as non-steroidal anti-inflammatory (NSAID) eye drops and oral narcotic medication.
Interventions
- DRUG placebo
- DRUG Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2008-07 |
| Est. Completion | 2009-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00793910
The ClinicalTrials.gov registry entry for NCT00793910 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Walter Reed Army Medical Center, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00793910 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00793910 about?
NCT00793910 is a clinical study titled "Oral Gabapentin Versus Placebo for Treatment of Postoperative Pain Following Photorefractive Keratectomy". The purpose of this study is to determine the effectiveness of an oral medication called gabapentin in reducing pain after Photorefractive Keratectomy (PRK) eye surgery and to assess the frequency of use of rescue medication interventions, defined as non-steroidal anti-inflammatory (NSAID) eye drops...
What is the current status of trial NCT00793910?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2008-07. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00793910?
The interventions under investigation include: placebo (DRUG), Gabapentin (DRUG).
Who is sponsoring clinical trial NCT00793910?
This trial is sponsored by Walter Reed Army Medical Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.